CAS: 1245603-92-2
![2-Pyrimidinecarboxamide, N,N-dimethyl-5-[[2-methyl-6-[[(5-methyl-2-pyrazinyl)amino]carbonyl]-4-ben…](https://static.cymitquimica.com/products/IN/thumb/DA000M7C.jpg)
2-Pyrimidinecarboxamide, N,N-dimethyl-5-[[2-methyl-6-[[(5-methyl-2-pyrazinyl)amino]carbonyl]-4-benzofuranyl]oxy]-
CAS:1245603-92-2
Formula:
C22H20N6O4
Purity:
95%
Molecular weight:
432.432
Ref: IN-DA000M7C
| 1mg | 102.00 € | ||
| 2mg | 141.00 € | ||
| 5mg | 177.00 € | ||
| 10mg | 308.00 € | ||
| 25mg | 604.00 € | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Wednesday 26 Mar 2025
PF 04937319
CAS:1245603-92-2
PF 04937319 is a small molecule that has been designed to inhibit the activity of …
Formula:
C22H20N6O4
Purity:
Min. 95%
Molecular weight:
432.43 g/mol
Ref: 3D-VZB60392
| 25mg | 1,084.00 € | ||
| 50mg | 1,509.00 € | ||
| 100mg | 2,415.00 € |
Estimated delivery in United States, on Wednesday 7 May 2025
PF-04937319
CAS:1245603-92-2
PF-04937319 activates glucokinase (EC50=154.4μM) with low hypoglycemia risk, researched for type 2 diabetes treatment.
Formula:
C22H20N6O4
Purity:
98.61%
Color and Shape:
Solid
Molecular weight:
432.43
Ref: TM-T16479
| 1mg | 46.00 € | ||
| 2mg | 58.00 € | ||
| 5mg | 87.00 € | ||
| 10mg | 153.00 € | ||
| 25mg | 305.00 € | ||
| 50mg | 557.00 € | ||
| 1mL*10mM (DMSO) | 97.00 € |
Estimated delivery in United States, on Wednesday 28 May 2025
